acelyrin.comHealthcare / BioTech & PharmaFounded: 2020Funding to Date: $558MM
Acelyrin is a biopharma company that invests in, develops and commercializes life-changing innovative therapeutics and transformative medicines. Acelyrin partners with big pharmaceutical companies, early-stage startups, and academia with a blend of scientific, medical, operational, and company-building experience to bring its treatments and therapeutics to the public, and transform patient's lives through healing and wellbeing.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/09/2022 | Series C | $300MM | $xx.xx | $809.52MM | Access Biotechnology, Cowen Healthcare Investments, Decheng Capital, Marshall Wace, Matrix Capital Management, Orbimed, Samsara Biocapital, Surveyor Capital, Tybourne Capital Management, Venbio Partners, Westlake Village Biopartners | |
Price per Share
$xx.xx
Shares Outstanding
48,230,736
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Access Biotechnology, Cowen Healthcare Investments, Decheng Capital, Marshall Wace, Matrix Capital Management, Orbimed, Samsara Biocapital, Surveyor Capital, Tybourne Capital Management, Venbio Partners, Westlake Village Biopartners
|
||||||
11/16/2021 | Series B | $250MM | $xx.xx | $364.33MM | Cowen Healthcare Investments, Decheng Capital, Marshall Wace, Matrix Capital Management, Orbimed, Samsara Biocapital, Surveyor Capital, Tybourne Capital Management, Venbio Partners, Westlake Village Biopartners | |
Price per Share
$xx.xx
Shares Outstanding
48,230,900
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cowen Healthcare Investments, Decheng Capital, Marshall Wace, Matrix Capital Management, Orbimed, Samsara Biocapital, Surveyor Capital, Tybourne Capital Management, Venbio Partners, Westlake Village Biopartners
|
||||||
12/15/2020 | Series A | $8MM | $xx.xx | $14.55MM | Westlake Village Biopartners | |
Price per Share
$xx.xx
Shares Outstanding
8,000,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Westlake Village Biopartners
|